The combination of pegylated interferon (Peg-IFN)-α plus ribavirin has provided a ‘cure’ for a considerable proportion of patients with chronic hepatitis C (CHC), particularly when most patients have the favorable interleukin-28B (IL-28B) genotype [5]. The gene discussed is IFNL3; the disease is chronic hepatitis C virus infection.